TSC-LAM results from mutations in genes TSC1 and TSC2, where it commonly manifests in the brain (e.g. seizures), renal (e.g. angiomyolipomas), and skin (e.g. lesions) divisions [3–5]. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.